Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rikke Olesen

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
AIDS (London, England)|April 15, 2015
The histone deacetylase inhibitor panobinostat lowers biomarkers of cardiovascular risk and inflammation in HIV patientsAnne Sofie Høgh Kølbæk Kjær, Christel Rothe Brinkmann, Charles A Dinarello, et al.
Journal of Clinical Medicine|October 23, 2021
Effect of Age on Innate and Adaptive Immunity in Hospitalized COVID-19 PatientsLamin B Cham, Marie Høst Pahus, Kristoffer Grønhøj, et al.
Plos One|October 29, 2020
Comparable human reconstitution following Cesium-137 versus X-ray irradiation preconditioning in immunodeficient NOG miceAnna Halling Folkmar Andersen, Stine Sofie Frank Nielsen, Rikke Olesen, et al.
Journal of Visualized Experiments : Jove|February 18, 2020
Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV InfectionAnna H F Andersen, Stine S F Nielsen, Rikke Olesen, et al.
Vaccine|October 15, 2025
TCR bias drives development of dominant vaccine-induced CD8+ T cell responses which can be redirected toward cellular targetsEmma Falling Iversen, Anna H F Rahimic, Giacomo S Frattari, et al.
Frontiers in Cellular and Infection Microbiology|July 22, 2022
CD169 (Siglec-1) as a Robust Human Cell Biomarker of Toll-Like Receptor 9 Agonist ImmunotherapyStine Sofie Frank Lende, Marie Høst Pahus, Ida Monrad, et al.
Immunology|March 29, 2019
cAIMP administration in humanized mice induces a chimerization-level-dependent STING responseAnna H F Andersen, Rikke Olesen, Kasper L Jønsson, et al.
Journal of Virology|July 31, 2015
Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with PanobinostatRikke Olesen, Selena Vigano, Thomas A Rasmussen, et al.
Journal of Virology|October 21, 2011
Generation of HIV latency in humanized BLT micePaul W Denton, Rikke Olesen, Shailesh K Choudhary, et al.
The Lancet. HIV|October 2, 2015
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trialThomas A Rasmussen, Martin Tolstrup, Christel R Brinkmann, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
AIDS (London, England)|April 15, 2015
The histone deacetylase inhibitor panobinostat lowers biomarkers of cardiovascular risk and inflammation in HIV patientsAnne Sofie Høgh Kølbæk Kjær, Christel Rothe Brinkmann, Charles A Dinarello, et al.
Journal of Clinical Medicine|October 23, 2021
Effect of Age on Innate and Adaptive Immunity in Hospitalized COVID-19 PatientsLamin B Cham, Marie Høst Pahus, Kristoffer Grønhøj, et al.
Plos One|October 29, 2020
Comparable human reconstitution following Cesium-137 versus X-ray irradiation preconditioning in immunodeficient NOG miceAnna Halling Folkmar Andersen, Stine Sofie Frank Nielsen, Rikke Olesen, et al.
Journal of Visualized Experiments : Jove|February 18, 2020
Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV InfectionAnna H F Andersen, Stine S F Nielsen, Rikke Olesen, et al.
Vaccine|October 15, 2025
TCR bias drives development of dominant vaccine-induced CD8+ T cell responses which can be redirected toward cellular targetsEmma Falling Iversen, Anna H F Rahimic, Giacomo S Frattari, et al.
Frontiers in Cellular and Infection Microbiology|July 22, 2022
CD169 (Siglec-1) as a Robust Human Cell Biomarker of Toll-Like Receptor 9 Agonist ImmunotherapyStine Sofie Frank Lende, Marie Høst Pahus, Ida Monrad, et al.
Immunology|March 29, 2019
cAIMP administration in humanized mice induces a chimerization-level-dependent STING responseAnna H F Andersen, Rikke Olesen, Kasper L Jønsson, et al.
Journal of Virology|July 31, 2015
Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with PanobinostatRikke Olesen, Selena Vigano, Thomas A Rasmussen, et al.
Journal of Virology|October 21, 2011
Generation of HIV latency in humanized BLT micePaul W Denton, Rikke Olesen, Shailesh K Choudhary, et al.
The Lancet. HIV|October 2, 2015
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trialThomas A Rasmussen, Martin Tolstrup, Christel R Brinkmann, et al.
Pageof 5